Immune Pharmaceuticals to Advance its Immuno-Dermatology and Inflammatory
Bowel Disease Product Candidates
IMMUNE is focused on developing the next generation of monoclonal antibodies to
address significant unmet medical needs in
the treatment of cancer and inflammatory diseases. Our goal is to improve patients’ lives through targeted medicine.